Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for PCOS focus on managing symptoms and improving fertility.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

PCOS is a common hormonal disorder in women, treated with lifestyle changes, medication, and patient education.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Diabetes can lead to blindness and skin problems, and managing blood sugar and blood pressure is crucial to prevent these complications.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

PCOS is a long-term condition that needs more research for better understanding and treatment.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Possible link between androgens and COVID-19 severity; more research needed.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

Certain gene variants in estrogen receptors are linked to polycystic ovary syndrome, mainly affecting metabolism, in Tunisian women.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

Children with classic congenital adrenal hyperplasia have thicker heart fat and are at higher risk for heart problems and early atherosclerosis.

Frontal fibrosing alopecia is linked to hypothyroidism but doesn't affect quality of life.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

People with more knowledge about their hair loss condition and those who see it as a serious issue are more likely to seek treatment.

Knuckle Acanthosis Nigricans is common in Latin American youth and may indicate early insulin resistance, especially in those with normal weight.

A gene called BMAL1 plays a role in controlling hair growth.

MC4R gene variants not linked to female hair loss.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Patients with Lichen Planopilaris are more likely to have rosacea and skin cancer but less likely to have congestive heart failure, stroke, and glaucoma.

The study concluded that combination therapy with topical corticosteroids and hydroxychloroquine or finasteride is effective in treating Frontal fibrosing alopecia in Asians.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Androgenic Alopecia, a common hair loss condition, can be effectively treated with finasteride and other treatments.

Ginger supplements helped reduce symptoms and improve metabolic health in hypothyroid patients.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Smoking increases early hair loss risk in men; quitting may help prevent it.